NRx Pharmaceuticals logo

NRx Pharmaceuticals

NRXP | NASDAQ
Chart Builder DCF Calculator
$2.15
-$0.04 (-1.83%)
At close: Nov 16, 2026, 4:00 PM ET
$2.18
+$0.03 (+1.40%)
After-hours: Nov 16, 2026, 7:54 PM ET
-1.83%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
46
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #366/1021 (Top 36%)

Key Statistics

Market Data

Market Cap $93.84M
1D Range
2.05 2.20
52W Range
1.68 4.62

Valuation (TTM)

PE -2.91
PB -552.00
EV/EBITDA -3.13

Valuation (NTM)

Forward PE 8.94
Forward PEG 0.18
Price Target $2.00
Loading financial charts...

Profile

NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases. Its product port...

Sector Healthcare
Industry Biotechnology
Employees 29
IPO Date Dec 4, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 16, 2026
EPS
-$0.05
Beat +76.47%
REV
$1.16M
Miss -9.83%
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$2.00
Downside
-6.98%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.